| Ponca City Immediate Care, Llc | |
|
1201 E Hartford Ave Ponca City OK 74601-2018 | |
| (580) 762-1911 | |
| Not Available |
| Full Name | Ponca City Immediate Care, Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 1201 E Hartford Ave, Ponca City, Oklahoma |
| Authorized Official Name and Position | Chadwick Ross (MEDICAL DIRECTOR) |
| Authorized Official Contact | 4053177830 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ponca City Immediate Care, Llc 1201 E Hartford Ave Ponca City OK 74601-2018 Ph: (580) 762-1911 | Ponca City Immediate Care, Llc 1201 E Hartford Ave Ponca City OK 74601-2018 Ph: (580) 762-1911 |
| NPI Number | 1740837889 |
|---|---|
| Provider Enumeration Date | 08/22/2019 |
| Last Update Date | 08/22/2019 |
| Medicare PECOS PAC ID | 3173854437 |
|---|---|
| Medicare Enrollment ID | O20191017001462 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740837889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 261QU0200X | Clinic/center - Urgent Care | (* (Not Available)) | Secondary |
| Provider Name | Chadwick Benjamin Ross |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1750356861 PECOS PAC ID: 5294753760 Enrollment ID: I20051216000675 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
| Provider Name | Megan A Lawver |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821407180 PECOS PAC ID: 5698997138 Enrollment ID: I20141117001397 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
| Provider Name | Angela L Ziegler |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891128682 PECOS PAC ID: 9234365123 Enrollment ID: I20141122000169 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
| Provider Name | Amy Casey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053717546 PECOS PAC ID: 3678885738 Enrollment ID: I20150701001869 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
| Provider Name | Katie L Biby |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720451594 PECOS PAC ID: 7315249786 Enrollment ID: I20160104000031 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
| Provider Name | Abbey Louise Collier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235623950 PECOS PAC ID: 8022362193 Enrollment ID: I20181109000061 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
| Provider Name | Alysa Kay Pressnall |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902470834 PECOS PAC ID: 4183022080 Enrollment ID: I20211007000210 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
| Provider Name | Tammy Cullum |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1699309120 PECOS PAC ID: 2668801564 Enrollment ID: I20240103000589 |
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
News Archive
Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.
Synesis, a University of Wisconsin-Madison spinoff developing a patented formula for liquid nutrition, is advancing a plant-based additive designed to reduce or eliminate severe side effects of tube feeding.
A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchers.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
› Verified 8 days ago
Mark Oatman Md Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 215 N 3rd St, Ponca City, OK 74601 Phone: 580-762-1777 Fax: 580-762-1771 | |
Dsk Medical Group, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 400 Fairview Ave, Building 3, Ste. 20, Ponca City, OK 74601 Phone: 580-765-6647 Fax: 580-765-6699 | |
Bruce Baugher D.o., Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1908 N 14th St, Suite 207, Ponca City, OK 74601 Phone: 580-763-5900 Fax: 580-763-5901 | |
Urgent Care And Family Practice Center Of Ponca City Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1715 N 5th St, Ponca City, OK 74601 Phone: 580-762-9292 Fax: 580-762-1660 | |
Lsi Clinics (lsi Foot, Shoe, Wound Or Orthotics) Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2210 N 14th St, Ponca City, OK 74604 Phone: 580-718-0002 Fax: 580-718-0003 | |
Bradley Bibb Md Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1201 E Hartford Ave, Ponca City, OK 74601 Phone: 580-762-1911 Fax: 580-762-0887 | |
John W. Holden, M.d., P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 427 Fairview Ave, Ponca City, OK 74601 Phone: 580-765-9299 Fax: 580-765-2199 |